United States Drug Enforcement Administration

WASHINGTON – Following the successful launch of the 2019 National Red Ribbon Campaign earlier this month with First Lady Melania Trump at the annual Red Ribbon Rally , DEA is encouraging communities nationwide to Go Red for Red Ribbon – an effort to continue the momentum and promote awareness of...

WASHINGTON – First Lady Melania Trump today joined DEA Acting Administrator Uttam Dhillon to celebrate the official launch of the 2019 Red Ribbon campaign, dedicated to preserving the memory of DEA Special Agent Enrique “Kiki” Camarena – a DEA special agent who was kidnapped, tortured, and murdered in Mexico by...

DENVER – United States Attorney Jason R. Dunn announced that Dr. Andrew Mark Ho, age 54, of Denver, pled guilty yesterday to illegally dispensing or illegally causing to be dispensed oxycodone, a controlled substance. Ho pled guilty before Chief U.S. District Court Judge Philip B. Brimmer. Judge Brimmer is scheduled...

SALT LAKE CITY – The Drug Enforcement Administration urges its DEA-registered practitioners and members of the public to be cautious of telephone calls from criminals posing as DEA or other law enforcement personnel threatening arrest and prosecution for supposed violations of federal drug laws or involvement in drug-trafficking activities. DEA...

GRAND JUNCTION, Colo. – United States Attorney Jason R. Dunn announced that Long Luong, aka “Peter”, was sentenced yesterday to serve 84 months (7 years) in federal prison for conspiracy to manufacture and possess with intent to distribute 1000 kilograms or more of marijuana and 1000 plants or more. The...

WASHINGTON – The U.S. Drug Enforcement Administration and the U.S. Food and Drug Administration have issued warning letters to four website owners of rogue online pharmacies offering to distribute or dispense controlled substances, including opioids, and advertising their sale in violation of federal law. This is the first time the...

WASHINGTON – In an effort to reduce the availability of deadly illegal fentanyl in America, the U.S. Drug Enforcement Administration has proposed to control three substances used by operators of clandestine laboratories to illicitly manufacture the deadly Schedule II controlled substance. Two Notices of Proposed Rulemaking were published in the...

WASHINGTON – The U.S. Drug Enforcement Administration is proposing to reduce the amount of five Schedule II opioid controlled substances that can be manufactured in the United States next year compared with 2019, per the Notice of Proposed Rulemaking being published in the Federal Register tomorrow and available for public...

WASHINGTON – The Drug Enforcement Administration today announced that it is moving forward to facilitate and expand scientific and medical research for marijuana in the United States. The DEA is providing notice of pending applications from entities applying to be registered to manufacture marijuana for researchers. DEA anticipates that registering...

WASHINGTON – The operator of a network of businesses in Lebanon and Africa, whom the United States Department of the Treasury designated as a financier of Lebanon-based terrorist group Hezbollah, was sentenced to five years in prison and ordered to forfeit $50 million by U.S. District Judge Reggie B. Walton...